We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Emergency Alerts Test on Sunday 7 September, 3pm
Check when packaging is classified as a finished plastic packaging component, and what is meant by substantial modifications, to find out if you must register for the tax.
Guidance on labelling for medicinal products used in clinical trials.
The NDA group has been allocated £154 million in government funding to develop specialised capabilities to enable plutonium disposal.
UK guideline on GMP for decentralised manufacturing, ensuring compliance with EU GMP principles for safe, quality medicinal products.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
As with any medicine, the MHRA will keep the safety of zuranolone under close review.
Guidance on using non-investigational medicinal products in a clinical trial.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).